|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online 12 October 2005
doi: 10.1242/dev.02079
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Departments of Developmental Biology, Genetics, and Bioengineering, Howard
Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA
94305-5439, USA
2 Department of Molecular and Cellular Physiology, Stanford University School of
Medicine, Stanford, CA 94305-5439, USA
* Author for correspondence (e-mail: scott{at}cmgm.stanford.edu)
Accepted 8 September 2005
Niemann-Pick type C (NPC) disease is a fatal autosomal-recessive neurodegenerative disorder characterized by the inappropriate accumulation of unesterified cholesterol in aberrant organelles. The disease is due to mutations in either of two genes, NPC1, which encodes a transmembrane protein related to the Hedgehog receptor Patched, and NPC2, which encodes a secreted cholesterol-binding protein. Npc1 mutant mice can be partially rescued by treatment with specific steroids. We have created a Drosophila NPC model by mutating dnpc1a, one of two Drosophila genes related to mammalian NPC1. Cells throughout the bodies of dnpc1a mutants accumulated sterol in a punctate pattern, as in individuals with NPC1 mutations. The mutants developed only to the first larval stage and were unable to molt. Molting after the normal first instar period was restored to various degrees by feeding the mutants the steroid molting hormone 20-hydroxyecdysone, or the precursors of ecdysone biosynthesis, cholesterol and 7-dehydrocholesterol. dnpc1a is normally highly expressed in the ecdysone-producing ring gland. Ring gland-specific expression of dnpc1a in otherwise mutant flies allowed development to adulthood, suggesting that the lack of ecdysone in the mutants is the cause of death. We propose that dnpc1a mutants have sterols trapped in aberrant organelles, leading to a shortage of sterol in the endoplasmic reticulum and/or mitochondria of ring gland cells, and, consequently, inadequate ecdysone synthesis.
Key words: Niemann-Pick Type C, Sterol, Steroid, Ecdysone, Drosophila, Lysosome storage
This article has been cited by other articles:
![]() |
D. D. Kaplan, G. Zimmermann, K. Suyama, T. Meyer, and M. P. Scott A nucleostemin family GTPase, NS3, acts in serotonergic neurons to regulate insulin signaling and control body size Genes & Dev., July 15, 2008; 22(14): 1877 - 1893. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Phillips, E. A. Woodruff III, P. Liang, M. Patten, and K. Broadie Neuronal Loss of Drosophila NPC1a Causes Cholesterol Aggregation and Age-Progressive Neurodegeneration J. Neurosci., June 25, 2008; 28(26): 6569 - 6582. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Talamillo, J. Sanchez, R. Cantera, C. Perez, D. Martin, E. Caminero, and R. Barrio Smt3 is required for Drosophila melanogaster metamorphosis Development, May 1, 2008; 135(9): 1659 - 1668. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Huang, J. T. Warren, J. Buchanan, L. I. Gilbert, and M. P. Scott Drosophila Niemann-Pick Type C-2 genes control sterol homeostasis and steroid biosynthesis: a model of human neurodegenerative disease Development, October 15, 2007; 134(20): 3733 - 3742. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yoshiyama, T. Namiki, K. Mita, H. Kataoka, and R. Niwa Neverland is an evolutionally conserved Rieske-domain protein that is essential for ecdysone synthesis and insect growth Development, July 1, 2006; 133(13): 2565 - 2574. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Xie, J. A. Richardson, S. D. Turley, and J. M. Dietschy Cholesterol substrate pools and steroid hormone levels are normal in the face of mutational inactivation of NPC1 protein J. Lipid Res., May 1, 2006; 47(5): 953 - 963. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Hickey, H. L. Chotkowski, N. Singh, J. G. Ault, C. A. Korey, M. E. MacDonald, and R. L. Glaser Palmitoyl-Protein Thioesterase 1 Deficiency in Drosophila melanogaster Causes Accumulation of Abnormal Storage Material and Reduced Life Span Genetics, April 1, 2006; 172(4): 2379 - 2390. [Abstract] [Full Text] [PDF] |
||||